EN
HI

FREDUN PHARMACEUTICALS LI Share price

FREDUN

HealthcareSmall

674.05

25.60 (-3.66%)
Last updated on 13 May, 2025 | 15:48 IST
BUYSELL
Today's High

666.00

Today's Low

713.90

52 Week Low

955.50

52 Week High

955.50

The current prices are delayed, login to your account for live prices

Fredun Pharmaceuticals Chart

FREDUN PHARMACEUTICALS LI Share Key Metrics

Volume
8836.00
Market Cap
318.26 CR
LTQ@LTP
1@674.05
ATP
683.28
Var Margin
2132
Circuit Range
559.75-839.55
Delivery %
94.83
Value
60.37 L
ASM/GSM
No
Market Lot
1

FREDUN PHARMACEUTICALS LI Futures & Options

Data Not Found

FREDUN PHARMACEUTICALS LI Corporate Actions

DateAgenda
2025-02-04Quarterly Results
DateEvent TypeAgenda
2025-02-04Board MeetingQuarterly Results

FREDUN PHARMACEUTICALS LI News

No Data Found

About FREDUN PHARMACEUTICALS LI

NSE : 0  
BSE : 539730  
ISIN : INE194R01017  

FREDUN PHARMACEUTICALS LIMITED is promoted by qualified andexperienced technocrats Mr. Nariman Medhora andDr.(Mrs.)Daulat Nariman Medhora.The promoters ventured into the business nine years ago andestablished a proprietary firm by the name and style ofD.N.Pharma for manufacture and export of pharmaceuticalformulations. The exports were mainly to Afghanistan WestAfrica D.N.Pharma has over 15 branded products covering awide range of applications as follows:--------------------------------------------------------------------------BRAND NAME DOSAGE FORM BULK DRUG APPLICATION--------------------------------------------------------------------------Neozoline Nasal Drop Xylometazoline Hydrochloride Decongestant DropsDolnacid Tablets Aluminium Hyrdoxide/Magnesium Antacid Tablets Hydroxide + SimethiconeNucee Drops Vitamin C Vitamin DropsDiarnil-N- Syrup Neomycin Sulphate Kaolin. Antidarrhoeal PectinNeogesic Cream Diethylamine Salicylate Anti-inflammatory Analgesic creamNeoprofane Tablet Ibuprofen Anti-inflammatory TabletsNervigesic Tablet Analgin/Vitamin B1 B6 B12 Neurological Problem--------------------------------------------------------------------------Their products are well received in the exports markets andhave a good demand. Since 1993 D.N.Pharma''s operations havebeen phased out with a view to switch over the business toFredun Pharmaceuticals Limited henceforth known as FPL).FPL has 50% stake in D.N.Pharma. The above mentionedproducts were being manufactured by D.N.Pharma on loanlicense basis from other manufacturers.Since the Registrar Of Companies did not permit theinclusion of the initials `D & N'' in the name D.N.Pharmafor the purpose of conversion of D.N.Pharma into a LimitedCompany it was decided to convert Fredun PharmaceuticalsPrivate Limited which had been incorporated on 8th June1987 to a Public Limited Company. Subsequently FredunPharmaceutical Private Limited was converted into a PublicLimited Company on 15th March 1994 and renamed as M/SFredun Pharmaceuticals Limited.FPL has its Registered Office at 26 Manoj IndustrialPremises G.D.Ambekar Marg Wadala Mumbai 400 031. It wasset up with the objective of providing facilities for themanufacturing and marketing of various pharmaceuticalformulations such as Tablets Capsules Dry-Syrups andOintments. The Company then set up a formulation plant atPalghar District Thane which is about 75 Kms from Mumbai.The Company will be manufacturing formulations for both theDomestic as well as the International Market.FPL has been carrying out the manufacturing operations onloan license for reputed Pharmaceutical companies likeCIPLA. It has also manufactured for some merchant exportersincluding Merind. The details as on 31st August are aslisted below:------------------------------------------------------------Brand Name TIC/S* Qty/Mn) Bulk drug L/L-M/E# L/E$------------------------------------------------------------Ferovita C 10.07 Ferrous M/E E FumarateYurovite C 4.50 Ferrous M/E E Fumarate-- T 2.40 Paracetamol M/E EChemicillin C 2.10 Ampicillin L/L EChemadol T 11.00 Paracetamol L/L EMetolar T 6.50 L/L LTheobid T 20.00 Theophylline L/L LIbugesic plus T 50.00 Ibuprofen L/L L Paracetamol-- T 12.00 Ferrous M/E E Fumarate-- T 17.00 Bisacodyl M/E E-- T 1.00 Pyrazinamide M/E ENovamox C 6.40 Amoxycillin L/L LPirox DT T 2.40 Piroxicam L/L LAmidol T 8.80 Paracetamol L/L EOxacilline C 0.50 Oxacillin L/L LNorflox TZ T 6.00 Norfloxacin L/L L Tinidazole------------------------------------------------------------* : T-Tablets C-Capsules S-Syrup# : L/L-Loan License M/E-Merchant Exports$ : L-Local E-ExportThe Company aims at producing high quality products. Theproducts are manufactured as per the Good ManufacturingPractices (GMP) Norms which assures quality safety andfreedom from harmful side effects.The GMP Norms cover a number of observance of basicprinciples and steps taken for the selection and trainingof personnel personal Industrial hygiene adequacy ofbuilding and premises production equipment including itsmaintenance and validation manufacturing and packagingprocesses including standard operating procedures qualityassurance raw and packing materials labelingdistribution warehousing and documentation.The Company has been granted the GMP certificate Food andDrugs Administration Maharashtra State and has applied forthe World Health Organisation (WHO) GMP. The Company alsohas a well equipped Quality Control Laboratory which hasthe most modern equipments and instruments to undertakechemical instrumental and microbiological analysis. Theplant is manned by a team of qualified and experiencedpersonnel. The firm has obtained all proper licenses suchas License to Manufacture for Sale from the Food and DrugAdministration of the Maharashtra State.The construction of the factory building was completed in1993. The manufacturing unit commenced commercialproduction in August 1994.

FREDUN PHARMACEUTICALS LI Management

NamePosition
Dr.(Mrs.) Daulat N Medhora Chairman & Jt. M. D
Mr. Fredun Medhora Managing Director & CFO
Mr. Nariman Medhora Non Executive Director
Dr. Rohinton Kanga Ind. Non-Executive Director
Dr. Aspi Raimalwala Ind. Non-Executive Director
Read More

FREDUN PHARMACEUTICALS LI FAQs

The Buying Price of FREDUN PHARMACEUTICALS LI share is NaN For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy FREDUN PHARMACEUTICALS LI share to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of FREDUN PHARMACEUTICALS LI shares is 17.57. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio FREDUN PHARMACEUTICALS LI shares is 2.43. Useful to assess the stock's value relative to its book value.

To assess FREDUN PHARMACEUTICALS LI’s valuation compare Sector P/E, P/B which are 38.18 & 4.68 with sector averages, along with growth rates and financial metrics.

The Market Cap of FREDUN PHARMACEUTICALS LI is 318.26 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of FREDUN PHARMACEUTICALS LI share price is 955.50 & 635.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.